Can antiarrhythmic drugs survive survival trials?

[1]  A. Camm,et al.  Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die? , 1998, The American journal of cardiology.

[2]  M. Janse,et al.  Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials , 1997, The Lancet.

[3]  A. Hjalmarson,et al.  Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. , 1997, The American journal of cardiology.

[4]  M. Mosller.  Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: Rationale, design, and patient characteristics of the DIAMOND studies , 1997, Clinical cardiology.

[5]  L. Køber,et al.  Effect of angiotensin converting enzyme inhibition after acute myocardial infarction in patients with arterial hypertension , 1997 .

[6]  P. Heidenreich,et al.  Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. , 1997 .

[7]  S. Connolly,et al.  Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT , 1997, The Lancet.

[8]  A. Camm,et al.  Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT , 1997, The Lancet.

[9]  M. Malik,et al.  Step wise Strategy of Using Short‐ and Long‐Term Heart Rate Variability for Risk Stratification After Myocardial Infarction , 1996 .

[10]  R. Lazzara,et al.  Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart. , 1996, Journal of cardiovascular pharmacology.

[11]  Bertram Pitt,et al.  Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.

[12]  A. Camm,et al.  Spectral Turbulence Versus Time‐Domain Analysis of Signal‐Averaged ECG Used for the Prediction of Different Arrhythmic Events in Survivors of Acute Myocardial Infarction , 1996, Journal of cardiovascular electrophysiology.

[13]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[14]  A. Camm,et al.  Assessment of arrhythmias after myocardial infarction in the post-CAST era. , 1996, The Canadian journal of cardiology.

[15]  M. Schoenfeld,et al.  Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials. , 1996, Circulation.

[16]  A. Gentile,et al.  Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA). , 1995, American heart journal.

[17]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[18]  R. Kleiger.  Heart Rate Variability and Mortality and Sudden Death Post Infarction , 1995, Journal of cardiovascular electrophysiology.

[19]  J. Bourke,et al.  Does the induction of ventricular flutter or fibrillation at electrophysiologic testing after myocardial infarction have any prognostic significance? , 1995, The American journal of cardiology.

[20]  P. Kulakowski,et al.  Wavelet decomposition of the signal averaged electrocardiogram used for the risk stratification after acute myocardial infarction , 1994, Computers in Cardiology 1994.

[21]  H. Doval,et al.  Randomised trial of low-dose amiodarone in severe congestive heart failure , 1994, The Lancet.

[22]  A. Camm,et al.  The European Myocardial Infarct Amiodarone Trial (EMIAT) , 1993 .

[23]  C. Furberg,et al.  Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. , 1993, JAMA.

[24]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[25]  L. Valenti,et al.  Secondary prevention after acute myocardial infarction. , 1993, The American journal of cardiology.

[26]  C. Viscoli,et al.  -Blockers after Myocardial Infarction: Influence of First-Year Clinical Course on Long-Term Effectiveness , 1993, Annals of Internal Medicine.

[27]  S. Yusuf,et al.  Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. , 1992, Journal of the American College of Cardiology.

[28]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[29]  P. Sager,et al.  Prognostic significance of programmed ventricular stimulation in patients surviving complicated acute myocardial infarction: a prospective study. , 1992, American heart journal.

[30]  Lippincott Williams Wilkins,et al.  The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. , 1991, Circulation.

[31]  A. Camm,et al.  Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. , 1991, Journal of the American College of Cardiology.

[32]  O Odemuyiwa,et al.  Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. , 1991, The American journal of cardiology.

[33]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[34]  M. Pfisterer,et al.  Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS) , 1990, Journal of the American College of Cardiology.

[35]  M Malik,et al.  Circadian rhythm of heart rate variability after acute myocardial infarction and its influence on the prognostic value of heart rate variability. , 1990, The American journal of cardiology.

[36]  A J Camm,et al.  Significance of long term components of heart rate variability for the further prognosis after acute myocardial infarction. , 1990, Cardiovascular research.

[37]  H. Wellens,et al.  The approach to nonsustained ventricular tachycardia after a myocardial infarction. , 1990, Circulation.

[38]  D. Wilber,et al.  Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. , 1990, Circulation.

[39]  Waspe E,et al.  Timing of treatment with oxygen radical scavengers and its influence on reperfusion injury. , 1989, British heart journal.

[40]  D. Warrell.  CEREBRAL CONSUMPTION OF GLUCOSE - REPLY , 1989 .

[41]  D. Seals,et al.  Influence of physical training on heart rate variability and baroreflex circulatory control. , 1989, Journal of applied physiology.

[42]  Irvin Jd,et al.  Antiarrhythmic effects of timolol in patients with ventricular arrhythmias. , 1988 .

[43]  D. Southall,et al.  Heart‐Rate Variability and SIDS Examination of Heart‐Rate Patterns Using an Expert System Generator a , 1988, Annals of the New York Academy of Sciences.

[44]  Cardiac Arrhythmia Pilot Study Investigators.  Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS. , 1988, The American journal of cardiology.

[45]  J. Fleiss,et al.  Components of heart rate variability measured during healing of acute myocardial infarction. , 1988, The American journal of cardiology.

[46]  A. Stančák,et al.  Spectral analysis of R-R interval variability in inspiratory breath holding in man at rest and during emotional strain. , 1987, Activitas nervosa superior.

[47]  C. Wyndham,et al.  Spontaneous arrhythmia detected on ambulatory electrocardiographic recording lacks precision in predicting inducibility of ventricular tachycardia during electrophysiologic study. , 1987, Journal of the American College of Cardiology.

[48]  A. Keren,et al.  Signal-averaged electrocardiographic late potentials in patients with ventricular fibrillation or ventricular tachycardia: correlation with clinical arrhythmia and electrophysiologic study. , 1985, The American journal of cardiology.

[49]  E. Gang,et al.  Sudden cardiac death following acute myocardial infarction. , 1985, American heart journal.

[50]  J P Miller,et al.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. , 1984, Circulation.

[51]  C. Furberg.  Effect of antiarrhythmic drugs on mortality after myocardial infarction. , 1983, The American journal of cardiology.

[52]  M Borggrefe,et al.  Prognostic significance of late ventricular potentials after acute myocardial infarction. , 1983, European heart journal.

[53]  Pedersen Tr.  The Norwegian Multicenter Study of Timolol after Myocardial Infarction. , 1983 .

[54]  L. Rydén,et al.  A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. , 1983, The New England journal of medicine.

[55]  N Egelund,et al.  Spectral analysis of heart rate variability as an indicator of driver fatigue. , 1982, Ergonomics.

[56]  R. Prescott,et al.  CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION , 1982, The Lancet.

[57]  K. Swedberg,et al.  EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION A Double-blind Randomised Trial , 1981, The Lancet.

[58]  Freeman Dw,et al.  Analysis of heart rate patterns preceding fetal death. , 1977 .

[59]  R. O'Bannon,et al.  Relationship of reaction time to deceleration and variability of heart rate in nonretarded and retarded persons. , 1975, American journal of mental deficiency.

[60]  Friedberg Ck.  Computers in cardiology. , 1970, Progress in cardiovascular diseases.

[61]  A. J. Cumm,et al.  Electrophysiology, Pacing, and Arrhythmia , 1996 .

[62]  A J Camm,et al.  Spectral turbulence analysis versus time-domain analysis of the signal-averaged ECG in survivors of acute myocardial infarction. , 1994, Journal of electrocardiology.

[63]  E. Bates.  Effect of amiodarone on mortality after myocardial infarction , 1993 .

[64]  J. Fleiss,et al.  Predicting arrhythmic events after acute myocardial infarction using the signal-averaged electrocardiogram. , 1992, The American journal of cardiology.

[65]  Robert Lemery,et al.  Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. , 1992, The New England journal of medicine.

[66]  Michael R. Rosen,et al.  The 'Sicilian Gambit' - A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms , 1991 .

[67]  J F Leclercq,et al.  Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. , 1989, American heart journal.

[68]  W. Rogers,et al.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.

[69]  J. Zbilut,et al.  Decreased heart rate variability in significant cardiac events. , 1988, Critical care medicine.

[70]  C. Furberg,et al.  Secondary prevention after myocardial infarction: a review of short-term acute phase trials. , 1983, Progress in cardiovascular diseases.

[71]  B. Sayers,et al.  Analysis of heart rate variability. , 1973, Ergonomics.

[72]  C. R. D. Winter,et al.  Heart rate deceleration after erroneous responses , 1971 .